Idorsia Ltd (IDRSF)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 152.38 Million CHF | 56.93% |
| 2022 | 97.1 Million CHF | 174.7% |
| 2021 | 35.34 Million CHF | -50.74% |
| 2020 | 71.75 Million CHF | 201.26% |
| 2019 | 23.81 Million CHF | -60.71% |
| 2018 | 60.61 Million CHF | -61.65% |
| 2017 | 158.08 Million CHF | 0.0% |
| 2016 | - CHF | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 10.05 Million CHF | -53.25% |
| 2024 Q2 | 16.34 Million CHF | 62.53% |
| 2023 Q1 | 21.02 Million CHF | -61.14% |
| 2023 Q3 | 79.91 Million CHF | 167.01% |
| 2023 Q2 | 29.93 Million CHF | 42.35% |
| 2023 FY | 152.38 Million CHF | 56.93% |
| 2023 Q4 | 21.51 Million CHF | -73.08% |
| 2022 FY | 97.1 Million CHF | 174.7% |
| 2022 Q4 | 54.1 Million CHF | 160.87% |
| 2022 Q3 | 20.73 Million CHF | 21.44% |
| 2022 Q2 | 17.07 Million CHF | 229.5% |
| 2022 Q1 | 5.18 Million CHF | 4.12% |
| 2021 Q3 | 16.54 Million CHF | 137.47% |
| 2021 Q1 | 6.86 Million CHF | 17.91% |
| 2021 Q2 | 6.96 Million CHF | 1.44% |
| 2021 FY | 35.34 Million CHF | -50.74% |
| 2021 Q4 | 4.97 Million CHF | -69.9% |
| 2020 Q4 | 5.82 Million CHF | -25.09% |
| 2020 Q2 | 53.13 Million CHF | 957.91% |
| 2020 Q1 | 5.02 Million CHF | 21.18% |
| 2020 Q3 | 7.77 Million CHF | -85.37% |
| 2020 FY | 71.75 Million CHF | 201.26% |
| 2019 Q2 | 6.55 Million CHF | 0.0% |
| 2019 FY | 23.81 Million CHF | -60.71% |
| 2019 Q4 | 4.14 Million CHF | -36.79% |
| 2019 Q3 | 6.55 Million CHF | 0.0% |
| 2019 Q1 | 6.55 Million CHF | -83.98% |
| 2018 Q3 | 6.55 Million CHF | 0.0% |
| 2018 FY | 60.61 Million CHF | -61.65% |
| 2018 Q4 | 40.94 Million CHF | 524.34% |
| 2018 Q2 | 6.55 Million CHF | 0.0% |
| 2018 Q1 | 6.55 Million CHF | -96.54% |
| 2017 Q2 | 165.29 Million CHF | 0.0% |
| 2017 Q3 | - CHF | -100.0% |
| 2017 Q4 | 189.7 Million CHF | 0.0% |
| 2017 Q1 | - CHF | 0.0% |
| 2017 FY | 158.08 Million CHF | 0.0% |
| 2016 FY | - CHF | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | -23.938% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -64317.484% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -736.458% |
| BioStem Technologies, Inc. | 16.68 Million USD | -813.289% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| CSL Limited | 14.69 Billion USD | 98.963% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -7787.474% |
| Capstone Therapeutics Corp. | 48.35 Million USD | -215.147% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -23041.382% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -201138.709% |
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -866.119% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -864697.685% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 21.47 Million USD | -609.498% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -231743.354% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 5.9 Million USD | -2481.938% |
| Marizyme, Inc. | 645.81 Thousand USD | -23496.104% |
| Genus plc | 668.8 Million USD | 77.215% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 245.31 Million USD | 37.882% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -153834.582% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -37052.366% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| ContraFect Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -198420.082% |
| IMV Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -385511.62% |
| MultiCell Technologies, Inc. | 49.32 USD | -308973947.04% |
| ONE Bio Corp. | 52.29 Million USD | -191.39% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 49.72 Million USD | -206.482% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -311527.812% |
| Q BioMed Inc. | 284.35 Thousand USD | -53490.62% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -414.87% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | -5.022% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -27223.519% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -217594.286% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 999.00 USD | -15253753.854% |
| Enzolytics Inc. | 52.79 Thousand USD | -288531.715% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -24941.864% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 87.574% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -108559.317% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -24582.531% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 839.52 Million USD | 81.849% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| Kadimastem Ltd | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -15173.332% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -64317.484% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.36 Million USD | -11031.191% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | - USD | -Infinity% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -32067.268% |
| SYBLEU INC | 11.69 Thousand USD | -1302789.877% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -1856.426% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -1172100.0% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -385355.557% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -4476.156% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -2186.362% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -14566.603% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -491.4% |
| CSL Limited | 14.8 Billion USD | 98.97% |
| Cellectis S.A. | 755 Thousand USD | -20083.576% |